7 results on '"Cystic fibrosis -- Care and treatment -- Forecasts and trends"'
Search Results
2. RECON: AMGEN TAKES 20.5% STAKE IN BEIGENE; NOVARTIS COSENTYX FAILS TO TOP HUMIRA IN HEAD-TO-HEAD TRIAL
3. Gene Therapy For Cystic Fibrosis| A Drug Pipeline Analysis Report 2018| Technavio
4. Novel Drugs and Smart Devices for Respiratory Disorders, 2018-2030 - Evaluation of Approx. 135 Novel Drug Candidates Across Various Stages of Development
5. Novel Drugs and Smart Devices for Respiratory Disorders, 2018-2030 - Evaluation of Approx. 135 Novel Drug Candidates Across Various Stages of Development
6. Novel Drugs and Smart Devices for Respiratory Disorders, 2030 - Focus on Asthma, COPD and Cystic Fibrosis
7. Novel Drugs and Smart Devices for Respiratory Disorders, 2018-2030 - ResearchAndMarkets.com
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.